Publications in collaboration with researchers from University of Utah (8)

2022

  1. Assessing the Relationship Between Molecular Rejection and Parenchymal Injury in Heart Transplant Biopsies

    Transplantation, Vol. 106, Núm. 11, pp. 2205-2216

  2. Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies

    European heart journal, Vol. 43, Núm. 23, pp. 2237-2246

  3. Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 3, pp. 334-344

2021

  1. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

2020

  1. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials

    European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171

2010

  1. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients

    Journal of Heart and Lung Transplantation

2008

  1. Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation

    Clinical Transplantation, Vol. 22, Núm. 6, pp. 809-814

2007

  1. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients

    Clinical Transplantation, Vol. 21, Núm. 1, pp. 18-23